NEW YORK, Feb. 15, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of iRhythm Technologies, Inc..

Shareholders who purchased shares of IRTC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE

CLASS PERIOD

January 11, 2022 to May 30, 2023

ALLEGATIONS

According to the lawsuit, defendants falsely represented to investors that one of iRhythm's main products, the Zio AT monitor, was a real-time heart monitor intended for high-risk patients. Specifically, defendants repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients. As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the class period.

DEADLINE: April 8, 2024

Shareholders should not delay in registering for this class action. Register your information here.

NEXT STEPS FOR SHAREHOLDERS

Once you register as a shareholder who purchased shares of IRTC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 8, 2024. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: (646) 453-8903